产品详情
| 中文名称:5,6,7,7a-四氢噻吩并[3,2-c]吡啶-2(4H)-酮盐酸盐 | 英文名称:5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-onehydrochloride |
| CAS:115473-15-9 | 纯度规格: 99%+ HPLC |
| 产品类别: 医药中间体 |
| 级别: 医药级 |
2025-12-22
5,6,7,7a-四氢噻吩并[3,2-c]吡啶-2(4H)-酮盐酸盐
5,6,7,7a-Tetrahydrothieno[3,2-c]pyridine-2(4H)-onehydrochloride
25KG/RMB;100KG/RMB;500KG/RMB
99%+ HPLC
医药中间体
通用名（中文）：盐酸普拉格雷（B2）
通用名（英文）：Prasugrel Hydrochloride
CAS No.：389574-19-0
分子式：C20H20FNO3S.HCl
分子量：409.91
外 观：白色或类白色粉末。
稳定性：小试批影响因素完成，中试批进行至加3。
储存条件：30℃以下密封保存。
包装形式：内包装双层聚乙烯袋热合，外加铝箔袋热合，外包镀锌盖纸桶
包装规格：5kg/包、1.0kg/包、0.5kg/包、0.1kg/包
产品质量：
1.质量标准：基于USP41-NF36(S1)药典标准标准制定，现符合USP41-NF36(S1)药典标准。
2.可分别提供化工品API和GMP条件的API 。
3.特定服务：根据客户的需求，可以为客户提供产品特殊指标监控或通过调整生产工艺满足客户特殊质量需求。
关键字： 115473-15-9;盐酸普拉格雷中间体;海步医药;
公司简介
Beijing Hope Pharmaceutical Co., Ltd., established in 2005, is a high-tech enterprise with "chemical drug technology development-Process Optimization-Regulation registration and approval" as its core competence, and has won the title of "China Top 20 Pharmaceutical R&D Company" for several times. Hope Pharma actively builds one-stop service for drug CRO and CDMO, continuously expands its service areas, and establishes good cooperative relations with some leading pharmaceutical companies domestic and abroad.
Hope Pharma has over 20 years of experience in project evaluation, innovation-oriented patent around design, pre-clinical development, clinical trial practice, registration, marker authorization, etc..Our products involve anti-tumor, anti-depressant, anti-epileptic, anxiolytic, cardiovascular and cerebrovascular, digestive system, respiratory system and other indications.
Until now, more than 140 technology transform, over 90 registration approvals and 73 patents has been finished in Hope(including subsidiaries) for past 20 years, and has been rated as a national high-tech enterprise.
| 成立日期 |
2005-04-26
（21年）
|
注册资本 |
4284.6849 万元人民币
|
| 员工人数 |
100-500人 |
年营业额 |
￥ 1亿以上 |
| 主营行业 |
医药中间体,医药中间体,原料药,原料药 |
经营模式 |
工厂,定制,工厂,定制 |